Xiaofen Zhou

557 total citations
29 papers, 358 citations indexed

About

Xiaofen Zhou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Xiaofen Zhou has authored 29 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cancer Research. Recurrent topics in Xiaofen Zhou's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (4 papers). Xiaofen Zhou is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (4 papers). Xiaofen Zhou collaborates with scholars based in China and United States. Xiaofen Zhou's co-authors include Ouchen Wang, Erjie Xia, Adheesh Bhandari, Yanyan Shen, Xiaohua Zhang, Fan Yang, Yefeng Cai, Chen Zheng, Xiaohua Zhang and Yinghao Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Medicine and International Journal of Oncology.

In The Last Decade

Xiaofen Zhou

29 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofen Zhou China 11 188 132 91 53 51 29 358
Junguo Cao China 10 205 1.1× 114 0.9× 44 0.5× 33 0.6× 31 0.6× 20 361
Jianjie Zhao China 11 194 1.0× 163 1.2× 46 0.5× 68 1.3× 34 0.7× 16 345
Stefanie Stepanow Germany 7 132 0.7× 87 0.7× 44 0.5× 83 1.6× 22 0.4× 11 351
Juyong Liang China 10 195 1.0× 88 0.7× 54 0.6× 36 0.7× 74 1.5× 17 371
T Okura Japan 9 262 1.4× 35 0.3× 83 0.9× 62 1.2× 70 1.4× 22 515
Jae Won Cho South Korea 11 274 1.5× 111 0.8× 126 1.4× 114 2.2× 37 0.7× 33 579
Fariborz Rashid-Kolvear Canada 9 254 1.4× 60 0.5× 103 1.1× 61 1.2× 82 1.6× 19 471
Brigith Willemsen Netherlands 7 134 0.7× 27 0.2× 43 0.5× 38 0.7× 32 0.6× 13 384
C.J.N. Verkleij Netherlands 7 88 0.5× 84 0.6× 32 0.4× 67 1.3× 37 0.7× 7 305
Lin-ang Wang China 11 189 1.0× 117 0.9× 25 0.3× 56 1.1× 76 1.5× 17 356

Countries citing papers authored by Xiaofen Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiaofen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofen Zhou more than expected).

Fields of papers citing papers by Xiaofen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofen Zhou. The network helps show where Xiaofen Zhou may publish in the future.

Co-authorship network of co-authors of Xiaofen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofen Zhou. A scholar is included among the top collaborators of Xiaofen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofen Zhou. Xiaofen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Xiaoyan, et al.. (2024). Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve implantation. BMC Cardiovascular Disorders. 24(1). 448–448. 3 indexed citations
6.
Zhou, Xiaofen, et al.. (2019). LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia. Translational Cancer Research. 8(7). 2526–2534. 1 indexed citations
7.
Zhou, Xiaofen, Yingying Chen, Yinghao Wang, et al.. (2019). Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma. Journal of Cancer. 10(15). 3543–3552. 6 indexed citations
8.
Li, Yuefeng, Xiaofen Zhou, Endong Chen, et al.. (2019). <p>Lipase member H is a downstream molecular target of hypoxia inducible factor-1&alpha; and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines</p>. Cancer Management and Research. Volume 11. 931–941. 10 indexed citations
9.
Zheng, Chen, et al.. (2019). <p>NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT</p>. Cancer Management and Research. Volume 11. 2565–2578. 32 indexed citations
10.
Zhou, Xiaofen, et al.. (2019). LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia. Translational Cancer Research. 8(7). 2526–2534. 8 indexed citations
11.
Zhou, Xiaofen, Qingxuan Wang, Xiaohua Zhang, et al.. (2018). Clinical effect of <em>MUC1</em> and its relevance to <em>BRAF</em> V600E mutation in papillary thyroid carcinoma: a case&ndash;control study. Cancer Management and Research. Volume 10. 1351–1358. 4 indexed citations
13.
Zhou, Xiaofen, Erjie Xia, Adheesh Bhandari, et al.. (2018). LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer. Biochemical and Biophysical Research Communications. 503(1). 257–263. 16 indexed citations
14.
Xia, Erjie, Adheesh Bhandari, Yanyan Shen, et al.. (2018). LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Biochemical and Biophysical Research Communications. 496(2). 628–632. 27 indexed citations
15.
Xu, Jun, et al.. (2018). Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia. Medicine. 97(39). e12102–e12102. 16 indexed citations
16.
Zhou, Yili, Jingjing Xiang, Adheesh Bhandari, et al.. (2018). CLDN10 is Associated with Papillary Thyroid Cancer Progression. Journal of Cancer. 9(24). 4712–4717. 21 indexed citations
17.
Zhou, Xiaofen, Yefeng Cai, Endong Chen, et al.. (2018). TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway. Endocrine Pathology. 29(4). 310–316. 17 indexed citations
18.
Zhou, Xiaofen, et al.. (2018). Predictive Factors of Skip Metastasis in Papillary Thyroid Cancer. Medical Science Monitor. 24. 2744–2749. 17 indexed citations
19.
Chen, Jing, Xiaofen Zhou, Shuang Liu, et al.. (2017). Immunohistochemical investigation of topoIIβ, H3K27me3 and JMJD3 expressions in medulloblastoma. Pathology - Research and Practice. 213(8). 975–981. 4 indexed citations
20.
Schlenk, Daniel, et al.. (2002). Cloning and sequencing of cytochrome P450 2X1 from channel catfish (Ictalurus punctatus). Marine Environmental Research. 54(3-5). 391–394. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026